Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3a,Condition 3b 528,PhysGen Vascular data,vasodilation trait,,RS:0001626,F344-DccTn(sb-T2/Bart3)2.205Mcwi,female,84 days to 70 days,5,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.539,,0.0784,0.1753,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),62848,controlled sodium content diet (4 %) (for 14 days),phenylephrine (1 umol/l) (for 0.2 hours),acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours) 528,PhysGen Vascular data,vasodilation trait,,RS:0001626,F344-DccTn(sb-T2/Bart3)2.205Mcwi,male,84 days to 70 days,7,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.8783,,0.0593,0.157,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),62857,controlled sodium content diet (4 %) (for 14 days),phenylephrine (1 umol/l) (for 0.2 hours),acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours)